Brain procedure may weaken immune defenses, study warns
NCT ID NCT05621850
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how a brain procedure called embolization affects the immune system. Researchers will take blood samples from 78 patients before and after the procedure to measure immune markers. They want to understand why patients with brain arteriovenous malformations (AVMs) who get this treatment seem to develop more severe lung infections. The study compares these patients to those treated for brain aneurysms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Dimethylsulfoxide (DMSO) from embolization implant
- What this could lead to
- If it works, this could help doctors understand why some patients get more severe lung infections after brain embolization and possibly lead to better prevention strategies.
- What could go wrong
- This is a small observational study (78 participants) that only measures immune markers, not treatment outcomes. It may not prove a direct link between the procedure and infection risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL ARTERIO-VENOUS MALFORMATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Limoges University Hospital
Limoges, 87042, France